HCA Holdings upgraded to Buy from Neutral at Goldman Goldman upgraded HCA Holdings citing solid fundamentals and its relatively attractive integrated model. Price target raised to $39 from $31.
News For HCA From The Last 14 Days
Check below for free stories on HCA the last two weeks.